Proteus Digital Health
Ingestible sensors in pills to track medication compliance is technically fascinating but practically unsellable.
2001 → 2020
$500M
Healthcare/IoT
USA
IdeaProof AI Failure Score
What Happened: The Timeline
2001
Proteus founded to create ingestible health sensors
2017
FDA approves Abilify MyCite (sensor pill)
2019
Minimal adoption by doctors, patients, insurers
2020
Files for bankruptcy after 19 years
Root Causes
Proteus developed a sensor-embedded pill that transmitted data to a wearable patch when swallowed, tracking medication compliance. Despite $500M in funding and an FDA-approved product (Abilify MyCite), doctors wouldn't prescribe it, insurers wouldn't cover it, and patients didn't want surveillance pills. The technology raised profound ethical concerns about surveillance medicine. Proteus filed for bankruptcy in 2020 after nearly two decades.
Sources & References
Could This Failure Have Been Prevented?
IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Proteus Digital Health.